Publication & Citation Trends
Most Cited Works
Publications
155 total
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial PDF
Cited by 279
OpenAlex
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers
Cited by 121
OpenAlex
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer PDF
Cited by 141
OpenAlex
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine PDF
Cited by 136
OpenAlex
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Cited by 701
OpenAlex
A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates PDF
Cited by 253
OpenAlex
Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
Cited by 244
OpenAlex
Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity PDF
Cited by 146
OpenAlex
Research Topics
Immunotherapy and Immune Responses
(46)
Cervical Cancer and HPV Research
(40)
HIV Research and Treatment
(21)
Immune Cell Function and Interaction
(19)
Cancer Immunotherapy and Biomarkers
(12)
Frequent Co-Authors
Affiliations
ECRI Institute
Ministry of Food and Drug Safety
Roswell Park Comprehensive Cancer Center
Johns Hopkins University
George Washington University